Medtronic (Minneapolis) received a crucial component in bringing its CoreValve system for transcatheter aortic valve implantation (TAVI) to the U.S. The med-tech giant reported last week that the FDA has given conditional approval for its investigational device exemption application and pivotal clinical trial protocol to evaluate the device.(Medical Device Daily)